TrialNature communications2024

Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study.

Hairong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.